Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-26 @ 3:14 PM
NCT ID: NCT07339761
Eligibility Criteria: Inclusion Criteria study 1a: * The participant has one of the following diagnoses and received initial treatment approximately 12 months ago: 1. Non-muscle-invasive bladder cancer treated with transurethral resection of the bladder (TUR-B) 2. Non-muscle-invasive bladder cancer treated with TUR-B and subsequent intravesical instillation therapy with chemotherapy or immunotherapy 3. Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder) * The participant has experienced changes and/or difficulties in sexual function related to the cancer diagnosis and/or its treatment * The participant speaks and understands Danish * The participant is aged 18 years or older * The participant has read and understood the oral and written study information * The participant has provided written informed consent Exclusion Criteria study 1a: * The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer, ovarian cancer, prostate cancer, or penile cancer * The participant has a history of breast cancer Inclusion Criteria study 1b: * The participant is diagnosed with Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder) * The participant speaks and understands Danish * The participant is aged 18 years or older * The participant has read and understood the oral and written study information * The participant has provided written informed consent Exclusion Criteria study 1b: * The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer, ovarian cancer, prostate cancer, or penile cancer * The participant has a history of breast cancer
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT07339761
Study Brief:
Protocol Section: NCT07339761